The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance - PubMed (original) (raw)
. 2001 Jun 1;309(2):437-45.
doi: 10.1006/jmbi.2001.4648.
Affiliations
- PMID: 11371163
- DOI: 10.1006/jmbi.2001.4648
The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance
Y Hsiou et al. J Mol Biol. 2001.
Abstract
Inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT) are widely used in the treatment of HIV infection. Loviride (an alpha-APA derivative) and HBY 097 (a quinoxaline derivative) are two potent non-nucleoside RT inhibitors (NNRTIs) that have been used in human clinical trials. A major problem for existing anti-retroviral therapy is the emergence of drug-resistant mutants with reduced susceptibility to the inhibitors. Amino acid residue 103 in the p66 subunit of HIV-1 RT is located near a putative entrance to a hydrophobic pocket that binds NNRTIs. Substitution of asparagine for lysine at position 103 of HIV-1 RT is associated with the development of resistance to NNRTIs; this mutation contributes to clinical failure of treatments employing NNRTIs. We have determined the structures of the unliganded form of the Lys103Asn mutant HIV-1 RT and in complexes with loviride and HBY 097. The structures of wild-type and Lys103Asn mutant HIV-1 RT in complexes with NNRTIs are quite similar overall as well as in the vicinity of the bound NNRTIs. Comparison of unliganded wild-type and Lys103Asn mutant HIV-1 RT structures reveals a network of hydrogen bonds in the Lys103Asn mutant that is not present in the wild-type enzyme. Hydrogen bonds in the unliganded Lys103Asn mutant but not in wild-type HIV-1 RT are observed between (1) the side-chains of Asn103 and Tyr188 and (2) well-ordered water molecules in the pocket and nearby pocket residues. The structural differences between unliganded wild-type and Lys103Asn mutant HIV-1 RT may correspond to stabilization of the closed-pocket form of the enzyme, which could interfere with the ability of inhibitors to bind to the enzyme. These results are consistent with kinetic data indicating that NNRTIs bind more slowly to Lys103Asn mutant than to wild-type HIV-1 RT. This novel drug-resistance mechanism explains the broad cross-resistance of Lys103Asn mutant HIV-1 RT to different classes of NNRTIs. Design of NNRTIs that make favorable interactions with the Asn103 side-chain should be relatively effective against the Lys103Asn drug-resistant mutant.
Copyright 2001 Academic Press.
Similar articles
- Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.
Das K, Sarafianos SG, Clark AD Jr, Boyer PL, Hughes SH, Arnold E. Das K, et al. J Mol Biol. 2007 Jan 5;365(1):77-89. doi: 10.1016/j.jmb.2006.08.097. Epub 2006 Sep 15. J Mol Biol. 2007. PMID: 17056061 - Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.
Das K, Ding J, Hsiou Y, Clark AD Jr, Moereels H, Koymans L, Andries K, Pauwels R, Janssen PA, Boyer PL, Clark P, Smith RH Jr, Kroeger Smith MB, Michejda CJ, Hughes SH, Arnold E. Das K, et al. J Mol Biol. 1996 Dec 20;264(5):1085-100. doi: 10.1006/jmbi.1996.0698. J Mol Biol. 1996. PMID: 9000632 - Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance.
Hsiou Y, Das K, Ding J, Clark AD Jr, Kleim JP, Rösner M, Winkler I, Riess G, Hughes SH, Arnold E. Hsiou Y, et al. J Mol Biol. 1998 Nov 27;284(2):313-23. doi: 10.1006/jmbi.1998.2171. J Mol Biol. 1998. PMID: 9813120 - Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
Balzarini J. Balzarini J. Curr Top Med Chem. 2004;4(9):921-44. doi: 10.2174/1568026043388420. Curr Top Med Chem. 2004. PMID: 15134549 Review. - HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors.
Menéndez-Arias L, Betancor G, Matamoros T. Menéndez-Arias L, et al. Antiviral Res. 2011 Nov;92(2):139-49. doi: 10.1016/j.antiviral.2011.08.020. Epub 2011 Aug 28. Antiviral Res. 2011. PMID: 21896288 Review.
Cited by
- Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.
Pata JD, Stirtan WG, Goldstein SW, Steitz TA. Pata JD, et al. Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10548-53. doi: 10.1073/pnas.0404151101. Epub 2004 Jul 12. Proc Natl Acad Sci U S A. 2004. PMID: 15249669 Free PMC article. - Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.
Schauer G, Leuba S, Sluis-Cremer N. Schauer G, et al. Biomolecules. 2013 Nov 1;3(4):889-904. doi: 10.3390/biom3040889. Biomolecules. 2013. PMID: 24970195 Free PMC article. - Mechanistic Study of Common Non-Nucleoside Reverse Transcriptase Inhibitor-Resistant Mutations with K103N and Y181C Substitutions.
Lai MT, Munshi V, Lu M, Feng M, Hrin-Solt R, McKenna PM, Hazuda DJ, Miller MD. Lai MT, et al. Viruses. 2016 Sep 23;8(10):263. doi: 10.3390/v8100263. Viruses. 2016. PMID: 27669286 Free PMC article. - Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H.
Kankanala J, Kirby KA, Liu F, Miller L, Nagy E, Wilson DJ, Parniak MA, Sarafianos SG, Wang Z. Kankanala J, et al. J Med Chem. 2016 May 26;59(10):5051-62. doi: 10.1021/acs.jmedchem.6b00465. Epub 2016 Apr 29. J Med Chem. 2016. PMID: 27094954 Free PMC article. - Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance.
Zhang J, Hou T, Wang W, Liu JS. Zhang J, et al. Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1321-6. doi: 10.1073/pnas.0907304107. Epub 2010 Jan 11. Proc Natl Acad Sci U S A. 2010. PMID: 20080674 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases